MESSA, PIERGIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 21.403
AS - Asia 18.548
EU - Europa 17.419
SA - Sud America 1.798
AF - Africa 436
OC - Oceania 167
Continente sconosciuto - Info sul continente non disponibili 18
Totale 59.789
Nazione #
US - Stati Uniti d'America 20.484
CN - Cina 6.117
SG - Singapore 5.459
GB - Regno Unito 4.513
IT - Italia 4.506
SE - Svezia 1.560
RU - Federazione Russa 1.509
HK - Hong Kong 1.369
DE - Germania 1.355
BR - Brasile 1.289
VN - Vietnam 1.267
FR - Francia 963
BD - Bangladesh 947
IN - India 760
IE - Irlanda 583
NL - Olanda 564
JP - Giappone 563
ID - Indonesia 470
CA - Canada 467
FI - Finlandia 413
MX - Messico 300
TR - Turchia 278
KR - Corea 251
ES - Italia 242
UA - Ucraina 190
TW - Taiwan 182
DK - Danimarca 180
AU - Australia 143
AR - Argentina 134
BE - Belgio 124
CO - Colombia 120
CI - Costa d'Avorio 104
CH - Svizzera 102
PL - Polonia 100
TH - Thailandia 95
PK - Pakistan 94
IR - Iran 88
AT - Austria 87
IQ - Iraq 85
EG - Egitto 80
GR - Grecia 75
PH - Filippine 75
MY - Malesia 66
SA - Arabia Saudita 66
ZA - Sudafrica 66
PE - Perù 64
EU - Europa 62
CL - Cile 58
PT - Portogallo 57
RO - Romania 55
MA - Marocco 50
VE - Venezuela 45
IL - Israele 43
NP - Nepal 40
UZ - Uzbekistan 36
EC - Ecuador 35
RS - Serbia 32
KE - Kenya 29
HR - Croazia 26
GT - Guatemala 25
JO - Giordania 25
TN - Tunisia 25
JM - Giamaica 24
CR - Costa Rica 23
HU - Ungheria 22
LT - Lituania 22
HN - Honduras 21
NO - Norvegia 21
NZ - Nuova Zelanda 21
BO - Bolivia 20
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 19
KZ - Kazakistan 18
DZ - Algeria 16
LU - Lussemburgo 16
PY - Paraguay 16
BG - Bulgaria 15
CY - Cipro 15
NG - Nigeria 15
OM - Oman 15
UY - Uruguay 14
SN - Senegal 13
LB - Libano 12
LK - Sri Lanka 12
AZ - Azerbaigian 11
SI - Slovenia 10
AL - Albania 9
DO - Repubblica Dominicana 9
SD - Sudan 9
SV - El Salvador 9
ET - Etiopia 8
KW - Kuwait 8
MK - Macedonia 8
PA - Panama 8
SY - Repubblica araba siriana 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
KH - Cambogia 7
LV - Lettonia 7
QA - Qatar 7
Totale 59.714
Città #
Southend 3.859
Singapore 3.087
Ashburn 1.863
Chandler 1.271
Fairfield 1.205
Hong Kong 1.197
San Jose 1.141
Houston 1.018
Milan 979
Beijing 975
Council Bluffs 812
Princeton 695
Dallas 659
Seattle 630
Wilmington 574
Woodbridge 570
Dublin 561
Redwood City 503
Los Angeles 498
Ann Arbor 477
Santa Clara 460
Nanjing 444
Cambridge 402
New York 379
Guangzhou 361
Lauterbourg 331
Hanoi 319
Ho Chi Minh City 311
Jakarta 299
Rome 299
Shenzhen 298
Dearborn 293
Helsinki 292
Boardman 275
Des Moines 272
Hanover 267
Buffalo 265
Frankfurt am Main 265
Bengaluru 264
Columbus 211
Hangzhou 211
Shanghai 207
Tokyo 207
The Dalles 191
Moscow 175
Jinan 163
Phoenix 160
Toronto 158
Hefei 153
Munich 146
Shenyang 142
São Paulo 133
Tianjin 130
Changsha 116
Cangzhou 113
Nanchang 113
Chicago 109
San Diego 107
Zhengzhou 107
Abidjan 104
Hebei 102
Naples 101
Jacksonville 99
Taipei 95
Bologna 91
London 90
Seoul 90
Istanbul 88
Brussels 80
Washington 80
Dong Ket 74
Nuremberg 70
Atlanta 69
Turin 67
Mountain View 65
Mumbai 64
Silver Spring 64
Redmond 60
Jiaxing 59
Bogotá 58
Berlin 56
Florence 56
Bangkok 54
Bari 54
Fuzhou 54
Montreal 54
Central District 53
Da Nang 53
Kunming 53
Ottawa 51
Madrid 49
Wuhan 49
Catania 46
Rio de Janeiro 46
Warsaw 46
Chengdu 44
San Francisco 40
Athens 39
Lanzhou 39
Lima 39
Totale 34.367
Nome #
Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 1.382
HCV, HBV, HIV ed emodialisi 1.318
Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier 889
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 792
Bone effects and safety of one year denosumab therapy in a cohort of renal transplanted patients: An observational monocentric study 777
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 747
Iperfosfatemia in dialisi: la scelta del chelante 672
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival 657
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 642
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome 517
Hepcidin levels in chronic hemodialysis patients : A critical evaluation 511
La doppia borsa di tabacco intorno alla cuffia profonda del catetere peritoneale: una tecnica per l’inizio immediato della CAPD [Double purse-string craft around the inner cuff: a new technique for an immediate start of CAPD] 477
Erythropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis 397
Metabolic acidosis in renal transplantation: Neglected but of potential clinical relevance 380
I nuovi farmaci antivirali per la terapia di HCV post- trapianto renale 379
Farmaci ad azione antivirale diretta, epatite C e dialisi: un aggiornamento 374
HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population 361
The long-term outcome of 93 patients with proliferative lupus nephritis 356
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey 344
NeuroD Expression in Podocytes and Interrelationships with Nephrin at Both Nuclear and Cytoplasmic Sites 326
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation 326
Podocytes: Recent biomolecular developments 321
Membranous Nephropathy (MN) Recurrence after Renal Transplantation 298
Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy] 285
A new approach for anemia in kidney disease 278
End-stage renal disease costs for patients new to hemodialysis in Italy: The FARO-2 Study 277
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 274
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: A secondary analysis of the EXCITE trial 274
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 270
How a skilful and motivated urinary sediment examination can save the kidneys 267
Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN) 265
Long-term evaluation of coronary artery calcifications in kidney transplanted patients : a follow up of 5 years 264
Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis 264
A dvanced glycation end products (ages) and soluble receptor for AGES (SRAGE): Association with risk of mortality in chronic kidney disease patients 263
FGF23-regulated production of Fetuin-A (AHSG) in osteocytes 261
Urgent-start PD: un approccio perseguibile 255
Pratica clinica per la diagnostica delle aritmie cardiache in pazienti in terapia renale sostitutiva: dati di una survey lombarda 252
Natural history of hepatitis B and C in renal allograft recipients 250
Vitamin K in Chronic Kidney Disease 249
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 245
Fluorinated-PLGA Nanoparticles for Enhanced Drug Encapsulation and 19F-NMR Detection 245
High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs 244
Physical performance and clinical outcomes in dialysis patients: A secondary analysis of the excite trial 239
Kinetics of hepatitis B virus load during haemodialysis sessions and α-interferon: A prospective study 239
Pathophysiology of calcium and phosphate metabolism impairment in Chronic Kidney Disease 235
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 235
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update 233
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study 232
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD 232
Trattamento dell’iperuricemia nel paziente nefropatico: è giunto il momento di agire? 232
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation 230
Luminex technology for anti-HLA antibody screening : evaluation of performance and of impact on laboratory routine 229
Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome 228
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations 228
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 227
Persistent secondary hyperparathyroidism after renal transplantation 226
Targeted silencing of GNAS in a human model of osteoprogenitor cells results in the deregulation of the osteogenic differentiation program 225
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 224
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial 224
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients 223
Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice? 223
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients : results of the FARO-2 Cohort 221
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism 219
Nutritional vitamin D in renal transplant patients : speculations and reality 217
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 217
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 216
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism 216
Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of literature 214
Graphene quantum dots : from efficient preparation to safe renal excretion 214
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 214
The role of immunosuppression in malignancies among 351 pediatric renal transplant patients 213
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: A novel model of glomerular damage 213
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome 213
Fitness for entering a simple exercise program and mortality: A study corollary to the exercise introduction to enhance performance in dialysis (Excite) trial EXCITE working group 212
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 211
Alport syndrome and pregnancy: a case series and literature review 208
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 208
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study 205
Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients 205
Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study 204
Vitamin B12 status in patients with renal failure 203
ANCA-associated vasculitis with renal involvement 203
Carotid plaques in patients with long-term lupus nephritis 202
Discoidin domain receptor-1 and periostin: New players in chronic kidney disease 201
Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers 201
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 201
Il trapianto renale nel Nord Italia Transplant program (NITp) : assegnazione degli organi e risultati = Renal transplantation in the North Italy Transplant program (NITp) : organ allocation and results 198
Malignancies in 2753 kidney recipients transplanted during a 39-year experience 197
Iron citrate reduces high-phosphate induced vascular calcification by inhibiting osteo-chondrogenic shift of extracellular matrix in VSMCs 197
Use of the Frailty Index in Older Persons with Chronic Kidney Disease 197
Advanced glycation end products (Age) and soluble forms of age receptor : Emerging role as mortality risk factors in CKD 197
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices 193
Pathophysiology of Non Alcoholic Fatty Liver Disease 193
Behaviour of phosphate removal with different dialysis schedules 191
ADPKD : clinical issues before and after renal transplantation 190
Vitamin and oxidative status in patients with systemic lupus erythematosus 189
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy 189
Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials 188
Novel markers of graft outcome in a cohort of kidney transplanted patients : a cohort observational study 188
Native Hypovitaminosis D in CKD Patients : From Experimental Evidence to Clinical Practice 188
Totale 30.535
Categoria #
all - tutte 164.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 0 0 0 0 0 0 441
2021/20224.965 426 237 234 349 337 365 605 330 398 429 363 892
2022/20235.368 570 434 462 571 656 919 156 419 539 148 289 205
2023/20243.789 201 334 210 238 689 301 210 217 133 250 416 590
2024/20259.949 643 934 350 712 813 594 494 1.119 612 822 1.010 1.846
2025/202619.284 1.707 1.005 1.682 1.323 1.819 1.293 2.102 908 2.506 1.182 2.684 1.073
Totale 62.352